These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30664481)

  • 21. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.
    Snowden JM; Chen YH; McFarland W; Raymond HF
    Sex Transm Infect; 2017 Feb; 93(1):52-55. PubMed ID: 27356041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
    Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
    Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai, China.
    Ding Y; Yan H; Ning Z; Cai X; Yang Y; Pan R; Zhou Y; Zheng H; Gao M; Rou K; Wu Z; He N
    Biosci Trends; 2016 May; 10(2):113-9. PubMed ID: 27052151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Discussions of Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex With Men.
    Halton BR; Roberts JNT; Denton GD
    Ochsner J; 2019; 19(3):188-193. PubMed ID: 31528127
    [No Abstract]   [Full Text] [Related]  

  • 26. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
    Grimshaw C; Boyd L; Smith M; Estcourt CS; Metcalfe R
    HIV Med; 2021 Nov; 22(10):965-970. PubMed ID: 34585494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
    Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J
    AIDS Behav; 2020 Aug; 24(8):2400-2408. PubMed ID: 31997057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
    Eustaquio PC; Burnett J; Prejean J; Chapin-Bardales J; Cha S;
    AIDS; 2024 Sep; ():. PubMed ID: 39229761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and Use of PEP and PrEP Among Key Populations Tested in Community Centers in Portugal.
    Simões D; Meireles P; Rocha M; Freitas R; Aguiar A; Barros H
    Front Public Health; 2021; 9():673959. PubMed ID: 34368050
    [No Abstract]   [Full Text] [Related]  

  • 33. Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair.
    Rocha LM; Campos MJ; Brito J; Fuertes R; Rojas J; Pinto N; Mendão L; Esteves J
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19734. PubMed ID: 25397480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing Laboratory Results to Identify Emergency Department Patients with Indications for HIV Pre-Exposure Prophylaxis.
    Carlisle NA; Booth JS; Rodgers JB; Heath SL; Walter LA
    AIDS Patient Care STDS; 2022 Aug; 36(8):285-290. PubMed ID: 35951447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Latent Class Analysis of Risk Factors for Acquiring HIV Among Men Who Have Sex with Men: Implications for Implementing Pre-Exposure Prophylaxis Programs.
    Chan PA; Rose J; Maher J; Benben S; Pfeiffer K; Almonte A; Poceta J; Oldenburg CE; Parker S; Marshall BD; Lally M; Mayer K; Mena L; Patel R; Nunn AS
    AIDS Patient Care STDS; 2015 Nov; 29(11):597-605. PubMed ID: 26389735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue).
    Lebouché B; Engler K; Machouf N; Lessard D; Thomas R
    HIV Med; 2016 Feb; 17(2):152-8. PubMed ID: 26177691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.
    Smith DJ; Jordan AE; Frank M; Hagan H
    BMC Infect Dis; 2016 Sep; 16(1):471. PubMed ID: 27595855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the Size of Key Populations in Kampala, Uganda: 3-Source Capture-Recapture Study.
    Doshi RH; Apodaca K; Ogwal M; Bain R; Amene E; Kiyingi H; Aluzimbi G; Musinguzi G; Serwadda D; McIntyre AF; Hladik W
    JMIR Public Health Surveill; 2019 Aug; 5(3):e12118. PubMed ID: 31407673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada.
    Kesler MA; Kaul R; Myers T; Liu J; Loutfy M; Remis RS; Gesink D
    AIDS Care; 2016 Nov; 28(11):1378-85. PubMed ID: 27136725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
    Siegler AJ; Mehta CC; Mouhanna F; Giler RM; Castel A; Pembleton E; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Sullivan PS
    Ann Epidemiol; 2020 May; 45():24-31.e3. PubMed ID: 32336655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.